search
Back to results

AKI Management Using Electronic Alerts

Primary Purpose

Acute Kidney Injury

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
electronic alert and clinical decision support system
Sponsored by
Seattle Children's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Acute Kidney Injury

Eligibility Criteria

6 Months - 18 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

All patients between 6 months-18 years admitted to the surgical and medical floors of Seattle Children's Hospital

Exclusion Criteria:

  1. History of chronic kidney disease stage 4 or worse (i.e., patients on chronic renal replacement therapy or glomerular filtration rate < 30 mL/min/1.73 m2)
  2. History of renal transplantation within the last 3 months
  3. History of nephrectomy within last 3 months
  4. Patients admitted to observation units

Sites / Locations

  • Seattle Children's Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Other

Arm Label

Baseline group

Alert group

Arm Description

This will be the pre and post alert phase where e-alerts will not be sent to providers

This will be the phase when e-alerts will be sent to the provider

Outcomes

Primary Outcome Measures

AKI documentation
Documentation of AKI in progress notes and discharge summary

Secondary Outcome Measures

AKI progression
Progression of AKI from Stage 1 to Stage 2/3

Full Information

First Posted
May 15, 2018
Last Updated
April 2, 2019
Sponsor
Seattle Children's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03538769
Brief Title
AKI Management Using Electronic Alerts
Official Title
Acute Kidney Injury: Integrating E-alerts and Clinical Decision Support System to Improve Outcomes
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
December 18, 2017 (Actual)
Primary Completion Date
October 16, 2018 (Actual)
Study Completion Date
October 16, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seattle Children's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Acute kidney injury (AKI) is a common clinical event with severe consequences. In the United States alone, greater than one million hospitalized patients per year are diagnosed with AKI. It has been independently associated with prolonged hospital stays, 25-80% risk of in-hospital death, and future progression to chronic kidney disease. While there has been an increase in awareness about the prevalence and significance of AKI, studies have uncovered systematic failure in the management of AKI, largely relating to the failure of clinicians to recognize and manage the condition appropriately. This is where we can use electronic health records (EHRs) and electronic alerts (e-alerts) to our advantage. In this study, the investigators plan to use e-alerts integrated into a clinical decision support (CDS) system to improve the care of and outcomes of patients with AKI. The aims are to study the prevalence of AKI and its progression among hospitalized patients using an 'AKI sniffer' (an EHR based automated system) and to prospectively study if introducing a complex intervention (an e-alert combined with a clinical decision support system) will reduce progression of AKI in children. The investigators have developed an AKI care bundle which provides simple guidelines for management of AKI along with specific discharge instructions to improve follow up care. The primary outcome is AKI progression. Secondary outcomes include morbidity, mortality, length of hospital stay, need for renal replacement therapy, and recovery of renal function by time of hospital discharge. The investigators will also look at documentation of AKI and if these participants get appropriate follow up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Kidney Injury

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
240 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Baseline group
Arm Type
No Intervention
Arm Description
This will be the pre and post alert phase where e-alerts will not be sent to providers
Arm Title
Alert group
Arm Type
Other
Arm Description
This will be the phase when e-alerts will be sent to the provider
Intervention Type
Other
Intervention Name(s)
electronic alert and clinical decision support system
Intervention Description
Providers taking care of patients will receive an electronic alert and will be guided to use a clinical decision support system
Primary Outcome Measure Information:
Title
AKI documentation
Description
Documentation of AKI in progress notes and discharge summary
Time Frame
28 days
Secondary Outcome Measure Information:
Title
AKI progression
Description
Progression of AKI from Stage 1 to Stage 2/3
Time Frame
7 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Months
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients between 6 months-18 years admitted to the surgical and medical floors of Seattle Children's Hospital Exclusion Criteria: History of chronic kidney disease stage 4 or worse (i.e., patients on chronic renal replacement therapy or glomerular filtration rate < 30 mL/min/1.73 m2) History of renal transplantation within the last 3 months History of nephrectomy within last 3 months Patients admitted to observation units
Facility Information:
Facility Name
Seattle Children's Hospital
City
Seattle
State/Province
Washington
ZIP/Postal Code
98105
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32620006
Citation
Menon S, Tarrago R, Carlin K, Wu H, Yonekawa K. Impact of integrated clinical decision support systems in the management of pediatric acute kidney injury: a pilot study. Pediatr Res. 2021 Apr;89(5):1164-1170. doi: 10.1038/s41390-020-1046-8. Epub 2020 Jul 3.
Results Reference
derived

Learn more about this trial

AKI Management Using Electronic Alerts

We'll reach out to this number within 24 hrs